About MedCath (NASDAQ:MDTH)
MedCath Corporation (MedCath) is a healthcare provider and focused on providing acuity services, including the diagnosis and treatment of cardiovascular disease. The Company owns and operates hospitals in partnership with physicians. Each of its majority-owned hospitals provides a range of health services with a focus on cardiovascular care. Each of its hospitals has around the clock-hour emergency room staffed by emergency department physicians. As of September 30, 2010, it owed interests in seven hospitals, including six in which it owned a majority interest. On November 1, 2010, the Company sold Heart Hospital of Austin. On December 31, 2010, the Company completed the sale of TexSan Heart Hospital to Methodist Healthcare System of San Antonio. On September 30, 2011, the Company sold Louisiana Medical Center & Heart Hospital to Cardiovascular Care Group. In December 2011, the Company announced that it has sold its ownership interest in Harlingen Medical Center and HMC Realty, LLC.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
MedCath (NASDAQ:MDTH) Frequently Asked Questions
What is MedCath's stock symbol?
MedCath trades on the NASDAQ under the ticker symbol "MDTH."
Who are some of MedCath's key competitors?
Some companies that are related to MedCath include Roche (ROG), Sanofi (SAN), Bayer (BAYN), CSL (CSL), GlaxoSmithKline (GSK), AstraZeneca (AZN), Covidien (COV), Beximco Pharmaceuticals (BXP), Shire (SHP), Essilor International (EI), C R Bard (BCR), Medivation (MDVN), Ramsay Health Care (RHC), CareFusion (CFN), AEGON (AGN), Bioverativ (BIVV), Cochlear (COH) and Salix Pharmaceuticals (SLXP).
Has MedCath been receiving favorable news coverage?
News coverage about MDTH stock has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. MedCath earned a news sentiment score of 0.15 on Accern's scale. They also gave news coverage about the health services provider an impact score of 46.91 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
How do I buy shares of MedCath?
Shares of MDTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact MedCath?
MedCath's mailing address is Corporation Trust Center 1209 Orange Street, New Castle County, WILMINGTON, DE 19801, United States. The health services provider can be reached via phone at +1-302-6587581.
MarketBeat Community Rating for MedCath (MDTH)MarketBeat's community ratings are surveys of what our community members think about MedCath and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
MedCath (NASDAQ:MDTH) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
MedCath (NASDAQ:MDTH) Earnings History and Estimates Chart
MedCath (NASDAQ MDTH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
MedCath (NASDAQ:MDTH) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for MedCath (NASDAQ:MDTH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for MedCath (NASDAQ MDTH)
No insider trades for this company have been tracked by MarketBeat.com
MedCath (NASDAQ MDTH) News Headlines
No headlines for this company have been tracked by MarketBeat.com
MedCath (NASDAQ:MDTH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
MedCath (NASDAQ:MDTH) Income Statement, Balance Sheet and Cash Flow Statement
MedCath (NASDAQ MDTH) Stock Chart for Tuesday, March, 20, 2018